Premium Information is available for this item - Upgrade for $1 a day
5961-01-392-6835
Solid State Scr
5961013926835 013926835 5037-329 2098993-003
INC: 77777
![]()
Managed by United States
NSN Created on 5 Jul 1994
Data Last Changed
January 2023
January 2023
NATO Update Count
5
5
NATO Data Quality

Marketplace 5961-01-392-6835
Need Help?
Request a Quotation from participating marketplace vendors
Request a Quotation from participating marketplace vendors
Related Documents 5961-01-392-6835 1+ Documents (More...)
5037-329 2098993-003 INC: 77777 Managed by United States NSN Created on 5 Jul 1994 Data Last Changed
5961-01-392-6835 1+ Documents ( More... ) https//www.nsnlookup.com /fsg-59/fsc-5961/us 5961-01-392-6835
RQST Updated Every Day 5961-01-392-6835 RQST NE Related Documents 5961-01-392-6835 1+ Documents
5961-01-392-6835 1+ Documents ( More... ) https//www.nsnlookup.com /fsg-59/fsc-5961/us 5961-01-392-6835
RQST Updated Every Day 5961-01-392-6835 RQST NE Related Documents 5961-01-392-6835 1+ Documents
Restrictions 5961-01-392-6835
5961-01-392-6835 is a Solid State Scr This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item is not suspected to be hazardous. This item does not contain a precious metal.
End Users 5961-01-392-6835
- Norway (ZT01)
- Effective Date:
- 1 May 1995
- NATO Maintenance and Supply Agency (ZX01)
- Effective Date:
- 1 Jul 1994
Approved Sources 5961-01-392-6835
- Part Number
- Manufacturer
- Status
- 5037-329
- Manufacturer
- 05869 - Raytheon Company (Active)
- Primary Buy
- Primary Buy
- 2098993-003
- 72393 - Castle Equipment Co (Obsolete)
- Canceled/Obsolete
- Canceled/Obsolete
Similar Supply Items to 5961-01-392-6835


















Freight Information 5961-01-392-6835
5961-01-392-6835 has freight characteristics.. 5961-01-392-6835 has a variance between NMFC and UFC when transported by rail and the description should be consulted.